comparemela.com
  1. Home
  2. Live Updates
  3. Margaret Van Gilse - Breaking News

Latest Breaking News On - Margaret van gilse - Page 1 : comparemela.com

Bexion Pharmaceuticals, Inc Announces First Patient Dosed with BXQ-350 in the ASIST Clinical Study

/PRNewswire/ Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing biologics for the treatment of cancer and neuropathy,.

United statesMargaret van gilseScott shivelyPrnewswire bexion pharmaceuticals incBexion pharmaceuticalsBexion pharmaceuticals incStudy aimsAssess safetyDouble blinded studyNewly diagnosed metastatic colorectal carcinomaGlioblastoma multiformeHealth care amp hospitalsMedical pharmaceuticalsClinical trials amp medical discoveries

Bexion Pharmaceuticals, Inc Announces First Patient Dosed with BXQ-350 in the ASIST Clinical Study

Study Aims to Assess Safety and Efficacy of BXQ-350 in Combination with Standard of Care for mCRCCOVINGTON, Ky., Jan. 10, 2023 /PRNewswire/ Bex.

United statesMargaret van gilseScott shivelyPrnewswire bexion pharmaceuticals incBexion pharmaceuticalsBexion pharmaceuticals incStudy aimsAssess safetyDouble blinded studyNewly diagnosed metastatic colorectal carcinomaGlioblastoma multiforme

Bexion Pharmaceuticals, Inc Announces First Patient Dosed with BXQ-350 in the RETRO Clinical Study

/PRNewswire/ Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing biologics for the treatment of cancer and neuropathy,.

United statesMargaret van gilseScott shivelyPrnewswire bexion pharmaceuticals incBexion pharmaceuticalsBexion pharmaceuticals incClinical research centerStudy aimsAssess potentialPrevalent limitationPilot proofCancer patientsChief executive officerResearch centerGlioblastoma multiforme

Bexion Pharmaceuticals, Inc Welcomes New Chief Financial Officer

/PRNewswire/ Bexion Pharmaceuticals, Inc., a mid-stage biopharmaceutical company developing innovative therapies for cancers and chemotherapy induced.

United statesMargaret van gilseJoyce laviscountScott shivelyNeither the companyBexion pharmaceuticalsBexion pharmaceuticals incChief executive officerGlioblastoma multiforme

Bexion Pharmaceuticals, Inc Welcomes New Chief Financial Officer

/PRNewswire/ Bexion Pharmaceuticals, Inc., a mid-stage biopharmaceutical company developing innovative therapies for cancers and chemotherapy induced.

United statesMargaret van gilseJoyce laviscountScott shivelyNeither the companyBexion pharmaceuticalsBexion pharmaceuticals incChief executive officerGlioblastoma multiforme

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.